Related Experiment Video

Updated: Jan 17, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.2K

SOCS3: An Immunological Biomarker Offering Potential Therapeutic Targets for Malignant Tumors

Yan Zhang1, Meiling Chu2, Meina Ye1

  • 1Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai, 200032, China.

Biological Procedures Online
|September 22, 2025
PubMed

Insights

Suppressor of Cytokine Signaling 3 (SOCS3) regulates cytokine signaling and impacts cancer. Abnormal SOCS3 expression drives tumor growth, making it a potential target for novel cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Suppressor of Cytokine Signaling 3 (SOCS3) is a key regulator of the Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway.
  • Aberrant SOCS3 expression is implicated in the development and progression of various malignancies.
  • Dysregulated SOCS3 influences cancer cell growth, migration, and apoptosis.

Purpose of the Study:

  • To provide a comprehensive overview of SOCS3's role in cancer.
  • To explore SOCS3's molecular structure, biological functions, and mechanisms in tumors.
  • To discuss therapeutic strategies targeting SOCS3 for cancer treatment.

Main Methods:

  • Literature review of studies on SOCS3 in cancer.
  • Analysis of SOCS3's involvement in cytokine and hormone signaling pathways.
  • Synthesis of information on SOCS3's diagnostic, prognostic, and therapeutic potential.

Main Results:

  • SOCS3 is crucial for regulating cytokine signaling and impacts tumor progression.
  • Abnormal SOCS3 expression correlates with uncontrolled cell proliferation and survival in cancer.
  • SOCS3 presents potential as a biomarker and therapeutic target in oncology.

Conclusions:

  • SOCS3 plays a significant role in cancer development and progression.
  • Targeting SOCS3 offers promising avenues for innovative cancer therapies.
  • Further research into SOCS3 mechanisms can enhance its clinical utility in oncology.
Keywords:
Immune MicroenvironmentImmune signalingImmune targetImmunotherapyMalignant TumorsSuppressor of Cytokine Signaling 3Therapeutic Target

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

3.8K
Three-Dimensional 3D Tumor Spheroid Invasion Assay12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

59.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K